Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

FluorNano Fluorinated polymer nanoparticles for mRNA-based cancer therapy

Coordinator
University College Cork - National University of Ireland, Cork, Ireland
Runs
1 April 2026 to 31 March 2028
Status
Running
EU funding
€253k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101268549

What the project is doing

In the project's own words, from its summary on CORDIS.

Global success of COVID-19 vaccines showcased mRNA as safe and effective tool for transient protein expression and opened avenuesfor innovative applications of mRNA in cancer therapy but efficient delivery to solid tumors and variable response rates toimmunotherapies remain the major obstacles to the development of mRNA-based cancer therapeutics. FluorNano aims torevolutionize cancer treatment by leveraging fluorine properties to enhance messenger RNA (mRNA) delivery, stability, cellularuptake, and therapy of aggressive cancers like Triple Negative Breast Cancer (TNBC) with poor survival rates.

FluorNano proposes anovel approach that involves developing fluorinated polymers for the delivery of mRNA to TNBC to express engineered HumanEpidermal Growth Factor Receptor 2 (HER2) that can sensitize cancer cells to approved anti-HER2 therapies such as Trastuzumab andTrastuzumab-Deruxtecan (T-DXd). FluorNano will last 2 years and will be conducted at University College of Cork, Ireland (24months), and also involve a secondment at i3S Institute of University of Porto (4 months) to evaluate the efficacy of fluorinated NPs in3D cancer models.

The project’s main objectives are to develop a library of fluorinated polymeric mRNA NPs, assess HER2 mRNAdelivery in vitro TNBC models, and evaluate the therapeutic efficacy of mRNA-based intervention in combination with anti-HER2therapies in animal models. FluorNano is committed to advancing cancer therapies and aligning with European missions, aiming tomake a lasting impact on cancer treatment and drive sustainable improvements in patient care.

The FluorNano project will advancemy career by offering advanced training, improving my research skills, and expanding my professional network, helping me becomean independent researcher. The public and scientific community will be informed about the project’s outcomes and the benefits ofRNA-based therapies through a targeted dissemination strategy.

Topics

Who is involved

OrganisationCityCountryRole
University College Cork - National University of Ireland, CorkCorkIrelandCoordinator
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI